Avenue Biosciences raised €4.9M in a Seed round in Jan 2026. The company is based in Helsinki, Finland. Investors in the round: Balnord, Dimerent, Inventure and 3 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
